Christopher B Umbricht

8PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersLiquid biopsiesCancer geneticsEpigenetics (incl. genome methylation and epigenomics)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 19, 2022
Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial.

Kala Visvanathan, Leslie Cope, Mary Jo Fackler

|Jun 24, 2021
Retrospective analysis of cancer-specific gene expression panel for thyroid fine needle aspiration specimens.

Yongchun Wang, Brittany A McKelvey, Zhiyang Liu

|Dec 11, 2020
Characterization of TERT and BRAF copy number variation in papillary thyroid carcinoma: An analysis of the cancer genome atlas study.

Brittany A McKelvey, Martha A Zeiger, Christopher B Umbricht

|Sep 13, 2020
Exploring the epigenetic regulation of telomerase reverse transcriptase (TERT) in human cancer cell lines.

Brittany A McKelvey, Martha A Zeiger, Christopher B Umbricht

|Jun 21, 2020
TERT promoter mutation determines apoptotic and therapeutic responses of BRAF-mutant cancers to BRAF and MEK inhibitors: Achilles Heel.

Jie Tan, Rengyun Liu, Guangwu Zhu

|Jul 14, 2019
DNA Methylation Markers for Breast Cancer Detection in the Developing World.

Bradley M Downs, Claudia Mercado-Rodriguez, Ashley Cimino-Mathews

Pageof 2